Pancreatic Cancer Research

ResearcherFudan UniversityActive in the last 2 years

Feng Shen

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5091637996, A5124037580. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2025: 2 papers · 2026: 2 papers

Papers 4

  1. Integrative single-cell and spatial transcriptomic approaches to decipher the tumor microenvironment and therapeutic resistance in pancreatic cancer. First author DOI 10.1080/15384047.2026.2699508↗
  2. Clinical efficacy of 2-week and 3-week albumin-bound paclitaxel therapy for advanced pancreatic cancer. Co-author DOI 10.1080/20565623.2026.2617117↗
  3. Real-world efficacy and safety of anlotinib combined with chemotherapy for advanced pancreatic cancer: a retrospective study. Co-author DOI 10.1080/20565623.2025.2532327↗
  4. Metastatic pancreatic cancer with activating BRAF V600E mutations: A case report. First author DOI 10.12998/wjcc.v13.i16.101665↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Fang Li · 1 shared paper, 2025 · strength 0.54
  2. Zhiyong Li · 1 shared paper, 2026 · strength 0.43
  3. Zhimin Su · 1 shared paper, 2026 · strength 0.43
  4. Mengting Luo · 1 shared paper, 2026 · strength 0.39
  5. Jin Wang · 1 shared paper, 2026 · strength 0.39
  6. Zhiyong Li · 1 shared paper, 2025 · strength 0.30
  7. Xiuping Zhang · 1 shared paper, 2025 · strength 0.30

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.